Andrew L. Pecora, Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 20,000 shares at $4.53 ($91K) on 2014-11-17, disclosed to the SEC on 2014-11-19.
Open-market purchase of $91k TLOG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NBS | BUY | 2014-11-25 | $50K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $186K | — | Filing → |
| CGIX | SELL | 2013-11-20 | $713K | — | Filing → |